NanoVation Therapeutics™

𝗥𝗮𝗿𝗲 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 𝗗𝗮𝘆 – 𝗠𝗮𝗸𝗲 𝗮𝗻 𝗜𝗺𝗽𝗮𝗰𝘁 🌍 We believe that every action can make a difference, no matter how big or small. This Rare Disease Day, we want to highlight the 𝗥𝗮𝗿𝗲 𝗧𝗿𝗮𝗶𝘁 𝗛𝗼𝗽𝗲 𝗔𝘀𝘀𝗼𝗰𝗶𝗮𝘁𝗶𝗼𝗻 and the 𝗦𝗶𝗰𝗸𝗹𝗲 𝗖𝗲𝗹𝗹 𝗔𝘀𝘀𝗼𝗰𝗶𝗮𝘁𝗶𝗼𝗻 in their fight against rare diseases. -> Rare Trait Hope Society: https://lnkd.in/geiPY_2s -> Sickle Cell Disease Association of Canada: https://lnkd.in/eHjJanhq We also encourage everyone to support blood donation services in your region, such as Canadian Blood Services, or EFS – A single blood, plasma, or platelet donation can save up to 𝘁𝗵𝗿𝗲𝗲 𝗹𝗶𝘃𝗲𝘀. Make an impact! Be the Difference!  𝗗𝗼𝗻𝗮𝘁𝗲 𝗯𝗹𝗼𝗼𝗱, 𝗽𝗹𝗮𝘀𝗺𝗮, 𝗼𝗿 𝗽𝗹𝗮𝘁𝗲𝗹𝗲𝘁𝘀 to save lives 𝗗𝗼𝗻𝗮𝘁𝗲 𝗺𝗼𝗻𝗲𝘆 to fuel research breakthroughs 𝗗𝗼𝗻𝗮𝘁𝗲 𝘆𝗼𝘂𝗿 𝘁𝗶𝗺𝗲 to raise awareness Together, we can change lives! #RareDiseaseDay #RareTraitHope #CureAGU #raredisease #BloodforLife #PartnersforLife 

𝗘𝘃𝗲𝗿𝘆 𝗯𝗿𝗲𝗮𝗸𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝘀𝘁𝗮𝗿𝘁𝘀 𝘄𝗶𝘁𝗵 𝗮 𝗯𝗼𝗹𝗱 𝗶𝗱𝗲𝗮—𝗮𝗻𝗱 𝘁𝗵𝗲 𝗿𝗶𝗴𝗵𝘁 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 𝘁𝗼 𝗯𝗿𝗶𝗻𝗴 𝗶𝘁 𝘁𝗼 𝗹𝗶𝗳𝗲. At 𝗡𝗮𝗻𝗼𝗩𝗮𝘁𝗶𝗼𝗻 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀, we are driven by a simple yet powerful purpose: 𝘁𝗼 𝗵𝗲𝗹𝗽 𝗽𝗲𝗼𝗽𝗹𝗲 𝗹𝗶𝘃𝗶𝗻𝗴 𝘄𝗶𝘁𝗵 𝗰𝗮𝗻𝗰𝗲𝗿, 𝗿𝗮𝗿𝗲 𝗱𝗶𝘀𝗲𝗮𝘀𝗲𝘀, 𝗮𝗻𝗱 𝗼𝘁𝗵𝗲𝗿 𝘀𝗲𝗿𝗶𝗼𝘂𝘀 𝗰𝗼𝗻𝗱𝗶𝘁𝗶𝗼𝗻𝘀 𝗯𝘆 𝗲𝗻𝗮𝗯𝗹𝗶𝗻𝗴 𝗹𝗶𝗳𝗲-𝗰𝗵𝗮𝗻𝗴𝗶𝗻𝗴 𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀. Our 𝗯𝗲𝘀𝘁-𝗶𝗻-𝗰𝗹𝗮𝘀𝘀 𝗹𝗶𝗽𝗶𝗱 𝗻𝗮𝗻𝗼𝗽𝗮𝗿𝘁𝗶𝗰𝗹𝗲 (#𝗟𝗡𝗣) 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 delivers 𝗻𝘂𝗰𝗹𝗲𝗶𝗰 𝗮𝗰𝗶𝗱-𝗯𝗮𝘀𝗲𝗱 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 with precision, helping scientists and biotech innovators turn groundbreaking research into real treatments for patients who need them most. 💡 𝗪𝗲 𝗯𝗲𝗹𝗶𝗲𝘃𝗲 𝗶𝗻 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻 By partnering with biotech and pharma leaders, we provide tailored LNP solutions that enhance 𝘀𝗮𝗳𝗲𝘁𝘆 𝗮𝗻𝗱 𝗲𝗳𝗳𝗶𝗰𝗮𝗰𝘆 - pushing the boundaries of 𝗴𝗲𝗻𝗲𝘁𝗶𝗰 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲. 𝗕𝗲𝗰𝗮𝘂𝘀𝗲 𝗯𝗲𝗵𝗶𝗻𝗱 𝗲𝘃𝗲𝗿𝘆 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻, 𝘁𝗵𝗲𝗿𝗲’𝘀 𝗮 𝗹𝗶𝗳𝗲 𝘄𝗮𝗶𝘁𝗶𝗻𝗴 𝘁𝗼 𝗯𝗲 𝗰𝗵𝗮𝗻𝗴𝗲𝗱. 📩 Let’s work together to accelerate the future of medicine. 🔗 Learn more about: Our Technology: https://lnkd.in/dVBQrCxE Our Partnership model: https://lnkd.in/dYHATETy #GeneticMedicine #RNA #LNP #Innovation #RareDiseases #Oncology #Therapeutics #Nanomedicine

𝗛𝗮𝘃𝗲 𝗮 𝘁𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰 𝗮𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗺𝗶𝗻𝗱?  We develop the 𝗯𝗲𝘀𝘁-𝗶𝗻-𝗰𝗹𝗮𝘀𝘀 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝘆 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 𝗳𝗼𝗿 𝘆𝗼𝘂. 📍Meet us at the RNA Leaders 𝗘𝘂𝗿𝗼𝗽𝗲 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 in Switzerland from 𝗠𝗮𝗿𝗰𝗵 𝟰-𝟲! Connect with our 𝗖𝗘𝗢 Dominik Witzigmann, PhD to explore how our cutting-edge 𝗹𝗶𝗽𝗶𝗱 𝗻𝗮𝗻𝗼𝗽𝗮𝗿𝘁𝗶𝗰𝗹𝗲 (𝗟𝗡𝗣) 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 enables the delivery of 𝗻𝘂𝗰𝗹𝗲𝗶𝗰 𝗮𝗰𝗶𝗱-𝗯𝗮𝘀𝗲𝗱 𝘁𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀—advancing innovation in genetic medicine. 🎥 𝗟𝗲𝗮𝗿𝗻 𝗺𝗼𝗿𝗲 𝗮𝗯𝗼𝘂𝘁 𝗼𝘂𝗿 𝗮𝗽𝗽𝗿𝗼𝗮𝗰𝗵 𝗶𝗻 𝗗𝗼𝗺’𝘀 𝗶𝗻𝘁𝗲𝗿𝘃𝗶𝗲𝘄 𝗳𝗿𝗼𝗺 𝗥𝗡𝗔 𝗟𝗲𝗮𝗱𝗲𝗿𝘀 𝗘𝗨 𝟮𝟬𝟮𝟯: https://lnkd.in/dEwHZ_6m #RNA #GeneticMedicine #LNP #Innovation #NucleicAcid #therapeutics #Nanotechnology

🔬 We’re Hiring: 𝗦𝗲𝗻𝗶𝗼𝗿 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗔𝘀𝘀𝗼𝗰𝗶𝗮𝘁𝗲, 𝗙𝗼𝗿𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻 Joins us for 𝗗𝗲𝗹𝗶𝘃𝗲𝗿𝗶𝗻𝗴 𝘁𝗼𝗺𝗼𝗿𝗿𝗼𝘄’𝘀 𝗴𝗲𝗻𝗲𝘁𝗶𝗰 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝘁𝗼𝗱𝗮𝘆 𝙩𝙤𝙙𝙖𝙮! NanoVation is looking for a 𝗱𝗲𝘁𝗮𝗶𝗹-𝗼𝗿𝗶𝗲𝗻𝘁𝗲𝗱 𝗮𝗻𝗱 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝘃𝗲 𝗦𝗲𝗻𝗶𝗼𝗿 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗔𝘀𝘀𝗼𝗰𝗶𝗮𝘁𝗲, 𝗙𝗼𝗿𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻 to help drive innovation in 𝗴𝗲𝗻𝗲𝘁𝗶𝗰 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝘆. In this role, you'll design, execute, and optimize #LNP formulations, contribute to cutting-edge research, and play a key role in advancing #nucleic acid therapeutics. 🔬 If you have experience in 𝗻𝗮𝗻𝗼- 𝗮𝗻𝗱 𝗺𝗶𝗰𝗿𝗼𝗽𝗮𝗿𝘁𝗶𝗰𝗹𝗲-𝗯𝗮𝘀𝗲𝗱 𝗱𝗿𝘂𝗴 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝘆 and a passion for pushing scientific boundaries, we’d love to hear from you! 📍 𝗟𝗼𝗰𝗮𝘁𝗶𝗼𝗻: Vancouver, BC 📩 𝗔𝗽𝗽𝗹𝘆 𝗻𝗼𝘄: https://lnkd.in/dVRivKvS #BiotechCareers #LNP #DrugDelivery #Formulation #GeneticMedicines #RNA #NucleicAci

📸 𝐉𝐚𝐧𝐮𝐚𝐫𝐲 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬 𝐚𝐭 𝐍𝐚𝐧𝐨𝐕𝐚𝐭𝐢𝐨𝐧 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 Our CEO, Dominik Witzigmann, PhD, presented at the 𝐒𝐰𝐢𝐬𝐬 𝐑𝐍𝐀 𝐓𝐱 𝐒𝐮𝐦𝐦𝐢𝐭, sharing insights on 𝒏𝒆𝒙𝒕-𝒈𝒆𝒏𝒆𝒓𝒂𝒕𝒊𝒐𝒏 𝑳𝑵𝑷 𝒕𝒆𝒄𝒉𝒏𝒐𝒍𝒐𝒈𝒊𝒆𝒔 𝒇𝒐𝒓 𝑹𝑵𝑨 𝒅𝒆𝒍𝒊𝒗𝒆𝒓𝒚 𝒃𝒆𝒚𝒐𝒏𝒅 𝒕𝒉𝒆 𝒍𝒊𝒗𝒆𝒓. We proudly sponsored the Life Sciences BC Career Day in Vancouver, where Jayesh Kulkarni, Mayara Brandao, Jessica Silva, and Lívia Palmerston Mendes represented NanoVation and connected with future biotech talents. We attended the 𝟒𝟑𝐫𝐝 𝐀𝐧𝐧𝐮𝐚𝐥 J.P. Morgan 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 in San Francisco, engaging in valuablepartnering discussions #JPMHC25. Our team members Rupsa Gupta and Nicola Pett attended the 𝐒𝐌𝐁𝐄 𝐍𝐢𝐠𝐡𝐭 at UBC, a great opportunity to network within the scientific community. We kicked off the year with a 𝐭𝐞𝐚𝐦-𝐛𝐮𝐢𝐥𝐝𝐢𝐧𝐠 𝐞𝐯𝐞𝐧𝐭 𝐢𝐧 𝐕𝐚𝐧𝐜𝐨𝐮𝐯𝐞𝐫, bringing our team together. Stay tuned—we have 𝐞𝐱𝐜𝐢𝐭𝐢𝐧𝐠 𝐧𝐞𝐰𝐬 𝐜𝐨𝐦𝐢𝐧𝐠 before the summer! #Biotech #RNA #LNP #GeneticMedicine #NucleicAcid #Innovation

3 New Talents join the NanoVation Team! Their arrival strengthens our preclinical efforts, now comprising 𝟑 𝐚𝐝𝐝𝐢𝐭𝐢𝐨𝐧𝐚𝐥 𝐭𝐚𝐥𝐞𝐧𝐭𝐞𝐝 𝐢𝐧𝐝𝐢𝐯𝐢𝐝𝐮𝐚𝐥𝐬 dedicated to advancing NanoVation’s mission:   𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐢𝐧𝐠 𝐭𝐨𝐦𝐨𝐫𝐫𝐨𝐰’𝐬 𝐠𝐞𝐧𝐞𝐭𝐢𝐜 𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞𝐬 𝐭𝐨𝐝𝐚𝐲. Parnian Mehinrad joins us as a 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐓𝐞𝐜𝐡𝐧𝐢𝐜𝐢𝐚𝐧, bringing over 5 years of experience in drug delivery with a focus on 𝐜𝐚𝐧𝐜𝐞𝐫 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡. Siobhan Ennis, steps into the role of 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐀𝐬𝐬𝐨𝐜𝐢𝐚𝐭𝐞, with expertise in virology, host-pathogen interactions, and 𝐯𝐚𝐜𝐜𝐢𝐧𝐞 𝐢𝐦𝐦𝐮𝐧𝐨𝐥𝐨𝐠𝐲. Robert Cadonic joins as a 𝐒𝐞𝐧𝐢𝐨𝐫 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐓𝐞𝐜𝐡𝐧𝐢𝐜𝐢𝐚𝐧, bringing extensive experience in 𝐚𝐧𝐢𝐦𝐚𝐥 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 and education through his previous roles as a Research Animal Technician and Science teacher. They join our current preclincal team: Grishma Pawar, Ph.D, Nicola Pett, Jessica Silva and Anthony T.. Welcome to the team, Parnian, Siobhan and Robert!  #NanoVationTx #Innovation #Biotech #Preclinical #LNP #RNA #NucleicAcid

🔬 NTx Focus on Sciences 🔬 Today we are sharing a scientific article from our co-founder, Christian Kastrup, recently published in Blood, the journal of the American Society of Hematology in collaboration with #NanoVationTherapeutics, the Kastrup lab explored an innovative application of genetic engineering utilizing #LNPs: a new cell therapy based on transfusable platelets. This innovative approach has the potential to transform how we treat bleeding disorders and perform transfusions. By engineering platelets with mRNA-LNP systems to improve their natural ability to clot, it opens the way to more effective medical treatments, especially for patients in critical situations like surgery or trauma. 📄 Read the full paper here: https://shorturl.at/dPEiv At NTx, we are pursuing innovations that transform global health. #NanoVation #Innovation #Biotech #Platelets #TransfusionMedicine #Healthcare #LNP #RNA #mRNA

Spotlight on Innovation: A Look Back at Our CEO Dominik Witzigmann, PhD's Interview with Life Science Connect! In this insightful article, science journalist Anna Rose Welch delves into groundbreaking advancements in the #RNA space. NanoVation Therapeutics, alongside other industry leaders, shared its perspective and expertise: Guillaume Pfefer, CEO, Sail Biomedicines Benita Nagel, Co-founder & CEO, and Albert Kwok, Co-founder & CSO, Nuntius Therapeutics Gopi Shanker, CSO, Beam Therapeutics Alexander Zehnder, MD, MBA, CEO, CureVac This Q&A sheds light on the future of RNA-LNP technologies and the pivotal role in shaping the next generation of genetic medicines. 📖 Read the full article here:  
https://lnkd.in/erQeyqvd #RNA #mRNA #Innovation #Biotech #LifeSciences #NanoVationTx #LNP #Geneticmedicines

🔬 We’re Hiring: Senior/Research Technician, Preclinical! NTx is looking for a detail-oriented and collaborative Senior/Research Technician, Preclinical to join our team. In this role, you'll design, execute, and analyze preclinical research, contribute to project plans, and support innovative genetic medicine development. 📩 Apply now: https://shorturl.at/o1RHX #LNP #RNA #NucleicAcid #Innovation #NanoVationTherapeutics

Kicking off 2025 with Enthusiasm and Ambition! At NanoVation Therapeutics, we are continuing on our bold aspirations for 𝐨𝐮𝐫 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲, 𝐨𝐮𝐫 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐬, 𝐚𝐧𝐝 𝐨𝐮𝐫 𝐭𝐚𝐥𝐞𝐧𝐭𝐞𝐝 𝐭𝐞𝐚𝐦. We are working diligently to develop unique solutions to complex delivery challenges, and we are fostering a culture that enables us to build a healthier world. 🌍💡To a year of innovation, collaboration, and impact! #Innovation #GeneticMedicine #NanoVationTx #RNA #LNP #Biotech